Evidence map›Paper›PMID 39519638›Full record

ArticleMolecules (Basel, Switzerland)2024

Construction of Co-Modified MXene/PES Catalytic Membrane for Effective Separation and Degradation of Tetracycline Antibiotics in Aqueous Solutions.

Xiaojie Cheng, Xiaojun Qin, Runxue Zhao, Jiamin Chen, Xia Zheng, Ke Liu, Meixuan Xin

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaojie ChengCollege of Life Science, Sichuan Normal University, Chengdu 610101, China.
Xiaojun QinCollege of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology, Chengdu 610059, China.
Runxue ZhaoCollege of Life Science, Sichuan Normal University, Chengdu 610101, China.
Jiamin ChenCollege of Life Science, Sichuan Normal University, Chengdu 610101, China.
Xia ZhengCollege of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology, Chengdu 610059, China.
Ke LiuCollege of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology, Chengdu 610059, China.
Meixuan XinCollege of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology, Chengdu 610059, China.

Funding

Teacher Development Research Start-up Fund of Sichuan Normal University XJKY1003
6 · The paper itself

Abstract

The application of antibiotics has advanced modern medicine significantly. However, the abuse and discharge of antibiotics have led to substantial antibiotic residues in water, posing great harm to natural organisms and humans. To address the problem of antibiotic degradation, this study developed a novel catalytic membrane by depositing Co catalysts onto MXene nanosheets and fabricating the polyethersulfone composite (Co@MXene/PES) using vacuum-assisted self-assembly. The dual role of MXene as both a carrier for Co atoms and an enhancer of interlayer spacing led to improved flux and catalytic degradation capabilities of the membrane. Experimental results confirmed that the Co@MXene/PES membrane effectively degraded antibiotics through peroxymonosulfate activation, achieving up to 95.51% degradation at a cobalt concentration of 0.01 mg/mL. The membrane demonstrated excellent antibacterial properties, minimal flux loss after repeated use, and robust anti-fouling performance, making it a promising solution for efficient antibiotic removal and stable water treatment.

Indexed as

Anti-Bacterial AgentsCobaltMembranes, ArtificialPolymersSulfonesCatalysisTetracyclineWaterWater Pollutants, ChemicalWater PurificationAnti-Bacterial AgentsCobaltMembranes, Artificialpolyether sulfonePolymersSulfonesTetracyclineWaterWater Pollutants, Chemicalantibiotic degradationCo atom catalystsMXene nanosheetsPMS activationwater treatment

Identifiers

PMID39519638
PMCPMC11547915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.